Complement system on the attack in autoimmunity

Research output: Contribution to journalReview article

18 Scopus citations


The antiphospholipid syndrome is characterized clinically by fetal loss and thrombosis and serologically by the presence of autoantibodies to lipid-binding proteins. In a model of this procoagulant condition in which these antibodies are injected into pregnant mice, fetal loss was prevented by blocking of complement activation. Specifically, interaction of complement component 5a (C5a) with its receptor is necessary for thrombosis of placental vasculature (see the related article beginning on page 1644). Inhibition of complement activation may have a therapeutic role in this disease.

Original languageEnglish
Pages (from-to)1639-1641
Number of pages3
JournalJournal of Clinical Investigation
Issue number11
StatePublished - Dec 2003

Fingerprint Dive into the research topics of 'Complement system on the attack in autoimmunity'. Together they form a unique fingerprint.

  • Cite this